Daniel B. Gilmer
Director · Armata Pharmaceuticals, Inc.
Individual
- 2026
- Apr 28, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Daniel B. Gilmer's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel B. Gilmer?
Daniel B. Gilmer is a corporate insider, tracked as Director of Armata Pharmaceuticals, Inc. (ARMP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Daniel B. Gilmer last file a Form 4?
The only primary Form 4 on record is dated 28 April 2026.